National Institute of Mental Health (NIMH) SBIR & STTR Programs are an important source of early-stage technology financing for small businesses, supporting small businesses to develop technologies including basic neuroscience research, translational and clinical research, clinical diagnosis and treatment, and dissemination and implementation of evidence-based research on mental disorders.
Learn more about how NIMH SBIR funding supported technology development for:
- 2020 Tibbetts Award winner Backyard Brains
- 2015 Tibbetts Award winner Behavior Imaging Solutions
- 2013 Tibbetts Award winner MBF Bioscience
- Floreo Technologies
- Pinnacle Technology
- Tetra Therapeutics
- UrSure Incorporated
NIMH does not endorse or recommend any commercial products or services. Inclusion of an author's views or opinions on our website does not constitute endorsement by NIMH, the National Institutes of Health (NIH), HHS, or the U.S. Government. Private parties may not use NIMH or author’s views or opinions on our website for advertising or product endorsement purposes. Reference herein to any specific commercial product, process, or service by trade name, trademark, manufacturer, or otherwise, does not constitute or imply its endorsement, recommendation, or favoring to the exclusion of other available products, processes, or services.
NIMH SBIR/STTR Program staff are eager to hear about the commercial successes of funded companies. We encourage you to connect with our contacts to share the commercialization successes that have resulted from NIMH SBIR funding.
Learn more about NIH’s SBIR and STTR Program successes.